Picture of Venus Remedies logo

VENUSREM — Venus Remedies News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: Venus Remedies Gets Marketing Approval For Carboplatin In Uzbekistan And Docetaxel And Irinotecan In Palestine

Feb 22 (Reuters) - Venus Remedies Ltd  VENR.NS :
    * GETS MARKETING APPROVAL FOR CANCER DRUGS FROM UZBEKISTAN,
PALESTINE
    * TO LAUNCH THESE DRUGS IN TWO COUNTRIES IN NEXT FINANCIAL
YEAR
    * GOT MARKETING APPROVAL FOR CARBOPLATIN IN UZBEKISTAN AND
DOCETAXEL AND IRINOTECAN IN PALESTINE

Source text for Eikon:  ID:nBSE9tFD06 
Further company coverage:  VENR.NS 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Venus Remedies

See all news